188 related articles for article (PubMed ID: 38153453)
1. VHL: Trends and Insight into a Multi-Modality, Interdisciplinary Approach for Management of Central Nervous System Hemangioblastoma.
Matloob SA; Paraskevopoulos D; O'Toole SM; Drake W; Plowman N; Foroglou N
Acta Neurochir Suppl; 2023; 135():81-88. PubMed ID: 38153453
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery for central nervous system hemangioblastoma in von Hippel-Lindau disease: A systematic review and meta-analysis.
Qiu J; Cai D; Yang F; Zhou J; Gong Y; Cai L; Gong K
Clin Neurol Neurosurg; 2020 Aug; 195():105912. PubMed ID: 32474257
[TBL] [Abstract][Full Text] [Related]
3. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
[TBL] [Abstract][Full Text] [Related]
4. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
5. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
7. A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease.
Padhi S; Sarangi R; Challa S; Bussary P; Panigrahi MK; Purohit AK
J Clin Neurosci; 2011 Jul; 18(7):939-44. PubMed ID: 21570297
[TBL] [Abstract][Full Text] [Related]
8. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
9. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
10. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Albiñana V; Escribano RMJ; Soler I; Padial LR; Recio-Poveda L; Villar Gómez de Las Heras K; Botella LM
Orphanet J Rare Dis; 2017 Jun; 12(1):122. PubMed ID: 28662711
[TBL] [Abstract][Full Text] [Related]
11. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
12. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.
Lonser RR; Butman JA; Huntoon K; Asthagiri AR; Wu T; Bakhtian KD; Chew EY; Zhuang Z; Linehan WM; Oldfield EH
J Neurosurg; 2014 May; 120(5):1055-62. PubMed ID: 24579662
[TBL] [Abstract][Full Text] [Related]
13. Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.
Vetrano IG; Gioppo A; Faragò G; Pinzi V; Pollo B; Broggi M; Schiariti M; Ferroli P; Acerbi F
Adv Exp Med Biol; 2023; 1405():377-403. PubMed ID: 37452946
[TBL] [Abstract][Full Text] [Related]
14. Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease.
Huntoon K; Wu T; Elder JB; Butman JA; Chew EY; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2016 Apr; 124(4):971-6. PubMed ID: 26517769
[TBL] [Abstract][Full Text] [Related]
15. Neurologic manifestations of von Hippel-Lindau disease.
Butman JA; Linehan WM; Lonser RR
JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic irradiation for optic nerve hemangioblastoma associated with Von Hippel-Lindau disease: a case report and literature review.
Lestrovaya AI; Golanov AV; Zolotova SV; Antipina NA; Kuznetsova AS
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):78-84. PubMed ID: 37830472
[TBL] [Abstract][Full Text] [Related]
17. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
18. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
19. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
20. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
Zamarud A; Marianayagam NJ; Park DJ; Yener U; Yoo KH; Meola A; Chang SD
J Neurooncol; 2023 Nov; 165(2):373-379. PubMed ID: 37955759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
